Rômulo Severo Sampaio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rômulo Severo Sampaio has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Isabelle Cristinne Pinto Costa
Universidade Federal de Alfenas
3 shared publications - Erika de Cássia Lopes Chaves
Universidade Federal de Alfenas, Brazil
2 shared publications - Ines Batinic-Haberle
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
2 shared publications - Ivan Spasojevic
Department of Medicine, Duke University, Durham, USA
2 shared publications - Julio Santos Reboucas
Departamento de Química, Centro de Ciências Exatas e da Natureza, Universidade Federal da Paraíba, João Pessoa, Brazil
2 shared publications - Andreia Cristina Barbosa Costa
Universidade Federal de Alfenas, Brazil
1 shared publication
Latest Publications
- Open Access
- 14 March 2024
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 46
Online scientific research on placentophagy: a bibliometric analysis
Objective: To classify the bibliometric indicators of online scientific research on placentophagy. Methods: A bibliometric study was conducted to quantify the scientific production of authors and institutions with the aim of highlighting the growth and impact of these publications nationally and internationally. The Bradford Law, network maps, and textual statistics were used, with searches […] Abstract Objective: To classify the bibliometric indicators of online scientific research on placentophagy. Methods: A bibliometric study was conducted to quantify the scientific production of authors and institutions with the aim of highlighting the growth and impact of these publications nationally and internationally. The Bradford Law, network maps, and textual statistics were used, with searches […]
- 14 March 2024
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 46
Open AccessOnline scientific research on placentophagy: a bibliometric analysis
Objective: To classify the bibliometric indicators of online scientific research on placentophagy. Methods: A bibliometric study was conducted to quantify the scientific production of authors and institutions with the aim of highlighting the growth and impact of these publications nationally and internationally. The Bradford Law, network maps, and textual statistics were used, with searches […] Abstract Objective: To classify the bibliometric indicators of online scientific research on placentophagy. Methods: A bibliometric study was conducted to quantify the scientific production of authors and institutions with the aim of highlighting the growth and impact of these publications nationally and internationally. The Bradford Law, network maps, and textual statistics were used, with searches […]
- Open Access
- 19 May 2023
- Published by Seven Events
- p. 724-733
Neurite óptica
O objetivo deste capítulo é apresentar o conceito, etiologia, fisiopatologia, manifestações clínicas, diagnóstico e formas de tratamento da neurite óptica. A neurite óptica é considerada um distúrbio visual agudo e grave, no qual, dependendo da etiologia, o prognóstico visual e o risco de lesões recorrentes podem variar. A neurite óptica se apresenta como infecção, inflamação e desmielinização envolvendo o nervo óptico, no qual é responsável pela recepção e transmissão de estímulos nervosos. Ainda, pode ser causada por uma reação autoimune direcionada contra este nervo. Tal distúrbio pode ocorrer de forma isolada ou se configurar como um sinal para outra patologia, como a esclerose múltipla. Acredita-se que as mulheres jovens sejam as mais afetadas, transformando a doença em uma das causas mais comuns de perda visual transitória em adultos jovens. Portanto, as características epidemiológicas típicas são sexo feminino, idade entre 20-50 anos e raça branca. Há duas principais apresentações clínicas de neurite óptica, típica e atípica, sendo importante distingui-las para detectar a etiologia subjacente e planejar o tratamento adequado e oportuno. O diagnóstico da neurite óptica depende da avaliação clínica e anamnese eficazes, bem como, de exames de laboratoriais e de imagens. O tratamento de formas típicas da neurite óptica é realizado com corticosteroides intravenosos em altas doses com objetivo de acelerar a recuperação visual. Formas atípicas podem necessitar de regimes prolongados de imunossupressores. No caso da neurite de origem infecciosa é necessário o uso de antibióticos ou quimioterápicos específicos.
- 19 May 2023
- Published by Seven Events
- p. 724-733
Open AccessNeurite óptica
O objetivo deste capítulo é apresentar o conceito, etiologia, fisiopatologia, manifestações clínicas, diagnóstico e formas de tratamento da neurite óptica. A neurite óptica é considerada um distúrbio visual agudo e grave, no qual, dependendo da etiologia, o prognóstico visual e o risco de lesões recorrentes podem variar. A neurite óptica se apresenta como infecção, inflamação e desmielinização envolvendo o nervo óptico, no qual é responsável pela recepção e transmissão de estímulos nervosos. Ainda, pode ser causada por uma reação autoimune direcionada contra este nervo. Tal distúrbio pode ocorrer de forma isolada ou se configurar como um sinal para outra patologia, como a esclerose múltipla. Acredita-se que as mulheres jovens sejam as mais afetadas, transformando a doença em uma das causas mais comuns de perda visual transitória em adultos jovens. Portanto, as características epidemiológicas típicas são sexo feminino, idade entre 20-50 anos e raça branca. Há duas principais apresentações clínicas de neurite óptica, típica e atípica, sendo importante distingui-las para detectar a etiologia subjacente e planejar o tratamento adequado e oportuno. O diagnóstico da neurite óptica depende da avaliação clínica e anamnese eficazes, bem como, de exames de laboratoriais e de imagens. O tratamento de formas típicas da neurite óptica é realizado com corticosteroides intravenosos em altas doses com objetivo de acelerar a recuperação visual. Formas atípicas podem necessitar de regimes prolongados de imunossupressores. No caso da neurite de origem infecciosa é necessário o uso de antibióticos ou quimioterápicos específicos.
- Open Access
- 1 June 2020
- Published by MDPI AG in Antioxidants
- Vol. 9 (6) , 467
Fe Porphyrin-Based SOD Mimic and Redox-Active Compound, (OH)FeTnHex-2-PyP4+, in a Rodent Ischemic Stroke (MCAO) Model: Efficacy and Pharmacokinetics as Compared to Its Mn Analogue, (H2O)MnTnHex-2-PyP5+
Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, (H2O)MnTnHex-2-PyP5+ (MnHex) carrying long hexyl chains, is a lipophilic mimic of superoxide dismutase (SOD) and a redox-active drug candidate. MnHex crosses the blood–brain barrier, and improved neurologic outcome and decreased infarct size and inflammation in a rat middle cerebral artery occlusion (MCAO) ischemic stroke model. Yet, the dose and the therapeutic efficacy of Mn porphyrin were limited by an adverse effect of arterial hypotension. An equally lipophilic Fe analog, (OH)FeTnHex-2-PyP4+ (FeHex), is as redox-active and potent SOD mimic in vitro. With different coordination geometry of the metal site, FeHex has one hydroxo (OH) ligand (instead of water) bound to the Fe center in the axial position. It has ~2 orders of magnitude higher efficacy than MnHex in an SOD-deficient E. coli model of oxidative stress. In vivo, it does not cause arterial hypotension and is less toxic to mice. We thus evaluated FeHex versus MnHex in a rodent MCAO model. We first performed short- and long-term pharmacokinetics (PK) of both porphyrins in the plasma, brain, and liver of rats and mice. Given that damage to the brain during stroke occurs very rapidly, fast delivery of a sufficient dose of drug is important. Therefore, we aimed to demonstrate if, and how fast after reperfusion, Fe porphyrin reaches the brain relative to the Mn analog. A markedly different plasma half-life was found with FeHex (~23 h) than with MnHex (~1.4 h), which resulted in a more than 2-fold higher plasma exposure (AUC) in a 7-day twice-daily treatment of rats. The increased plasma half-life is explained by the much lower liver retention of FeHex than typically found in Mn analogs. In the brain, a 3-day mouse PK study showed similar levels of MnHex and FeHex. The same result was obtained in a 7-day rat PK study, despite the higher plasma exposure of FeHex. Importantly, in a short-term PK study with treatment starting 2 h post MCAO, both Fe- and Mn- analogs distributed at a higher level to the injured brain hemisphere, with a more pronounced effect observed with FeHex. While a 3-day mouse MCAO study suggested the efficacy of Fe porphyrin, in a 7-day rat MCAO study, Mn-, but not Fe porphyrin, was efficacious. The observed lack of FeHex efficacy was discussed in terms of significant differences in the chemistry of Fe vs. the Mn center of metalloporphyrin; relative to MnHex, FeHex has the propensity for axial coordination, which in vivo would preclude the reactivity of the Fe center towards small reactive species.
- 1 June 2020
- Published by MDPI AG in Antioxidants
- Vol. 9 (6) , 467
Open AccessFe Porphyrin-Based SOD Mimic and Redox-Active Compound, (OH)FeTnHex-2-PyP4+, in a Rodent Ischemic Stroke (MCAO) Model: Efficacy and Pharmacokinetics as Compared to Its Mn Analogue, (H2O)MnTnHex-2-PyP5+
Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, (H2O)MnTnHex-2-PyP5+ (MnHex) carrying long hexyl chains, is a lipophilic mimic of superoxide dismutase (SOD) and a redox-active drug candidate. MnHex crosses the blood–brain barrier, and improved neurologic outcome and decreased infarct size and inflammation in a rat middle cerebral artery occlusion (MCAO) ischemic stroke model. Yet, the dose and the therapeutic efficacy of Mn porphyrin were limited by an adverse effect of arterial hypotension. An equally lipophilic Fe analog, (OH)FeTnHex-2-PyP4+ (FeHex), is as redox-active and potent SOD mimic in vitro. With different coordination geometry of the metal site, FeHex has one hydroxo (OH) ligand (instead of water) bound to the Fe center in the axial position. It has ~2 orders of magnitude higher efficacy than MnHex in an SOD-deficient E. coli model of oxidative stress. In vivo, it does not cause arterial hypotension and is less toxic to mice. We thus evaluated FeHex versus MnHex in a rodent MCAO model. We first performed short- and long-term pharmacokinetics (PK) of both porphyrins in the plasma, brain, and liver of rats and mice. Given that damage to the brain during stroke occurs very rapidly, fast delivery of a sufficient dose of drug is important. Therefore, we aimed to demonstrate if, and how fast after reperfusion, Fe porphyrin reaches the brain relative to the Mn analog. A markedly different plasma half-life was found with FeHex (~23 h) than with MnHex (~1.4 h), which resulted in a more than 2-fold higher plasma exposure (AUC) in a 7-day twice-daily treatment of rats. The increased plasma half-life is explained by the much lower liver retention of FeHex than typically found in Mn analogs. In the brain, a 3-day mouse PK study showed similar levels of MnHex and FeHex. The same result was obtained in a 7-day rat PK study, despite the higher plasma exposure of FeHex. Importantly, in a short-term PK study with treatment starting 2 h post MCAO, both Fe- and Mn- analogs distributed at a higher level to the injured brain hemisphere, with a more pronounced effect observed with FeHex. While a 3-day mouse MCAO study suggested the efficacy of Fe porphyrin, in a 7-day rat MCAO study, Mn-, but not Fe porphyrin, was efficacious. The observed lack of FeHex efficacy was discussed in terms of significant differences in the chemistry of Fe vs. the Mn center of metalloporphyrin; relative to MnHex, FeHex has the propensity for axial coordination, which in vivo would preclude the reactivity of the Fe center towards small reactive species.
- Open Access
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Texto & Contexto - Enfermagem
- Vol. 29
SCIENTIFIC PRODUCTION IN ONLINE JOURNALS ABOUT THE NEW CORONAVIRUS (COVID-19): BIBLIOMETRIC RESEARCH
Objective: to describe the bibliometric indicators of scientific production available in online journals that address Covid-19. Method: bibliometric study using Bradford's Law, network maps and textual statistics conducted with publications available in databases, from January to March 2020. Results: the sample consisted of 110 scientific articles. The main authors of the studies were linked to 83 institutions in 30 countries, giving priority to medical training. China was the country that published the most, providing a large number of research data. Patients infected with Covid-19 and the population in general made up the study populations and the hospital environment was the place where most of the research was performed. The journal with the highest number of publications has a high scientific influence among academic journals. The predominance of themes about Covid-19 was observed through the analysis of terms. Conclusion: bibliometric indicators indicate existing directions and gaps in the scientific production of Covid-19, which will assist in the development of future research, especially at the national level.
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Texto & Contexto - Enfermagem
- Vol. 29
Open AccessSCIENTIFIC PRODUCTION IN ONLINE JOURNALS ABOUT THE NEW CORONAVIRUS (COVID-19): BIBLIOMETRIC RESEARCH
Objective: to describe the bibliometric indicators of scientific production available in online journals that address Covid-19. Method: bibliometric study using Bradford's Law, network maps and textual statistics conducted with publications available in databases, from January to March 2020. Results: the sample consisted of 110 scientific articles. The main authors of the studies were linked to 83 institutions in 30 countries, giving priority to medical training. China was the country that published the most, providing a large number of research data. Patients infected with Covid-19 and the population in general made up the study populations and the hospital environment was the place where most of the research was performed. The journal with the highest number of publications has a high scientific influence among academic journals. The predominance of themes about Covid-19 was observed through the analysis of terms. Conclusion: bibliometric indicators indicate existing directions and gaps in the scientific production of Covid-19, which will assist in the development of future research, especially at the national level.
- 20 September 2018
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 29 (13) , 1196-1214
Radiation-Mediated Tumor Growth Inhibition Is Significantly Enhanced with Redox-Active Compounds That Cycle with Ascorbate
Aims: We aim here to demonstrate that radiation (RT) enhances tumor sensitization by only those Mn complexes that are redox active and cycle with ascorbate (Asc), thereby producing H 2 O 2 and utilizing it subsequently in protein S -glutathionylation in a glutathione peroxidase (GPx)-like manner. In turn, such compounds affect cellular redox environment, described by glutathione disulfide (GSSG)/glutathione (GSH) ratio, and tumor growth. To achieve our goal, we tested several Mn complexes of different chemical and physical properties in cellular and animal flank models of 4T1 breast cancer cell. Four other cancer cell lines were used to substantiate key findings. Results: Joint administration of cationic Mn porphyrin (MnP)-based redox active compounds, MnTE-2-PyP 5+ or MnTnBuOE-2-PyP 5+ with RT and Asc contributes to high H 2 O 2 production in cancer cells and tumor, which along with high MnP accumulation in cancer cells and tumor induces the largest suppression of cell viability and tumor growth, while increasing GSSG/GSH ratio and levels of total S -glutathionylated proteins. Redox-inert MnP, MnTBAP 3− and two other different types of redox-active Mn complexes (EUK-8 and M40403) were neither efficacious in the cellular nor in the animal model. Such outcome is in accordance with their inability to catalyze Asc oxidation and mimic GPx. Innovation: We provided here the first evidence how structure-activity relationship between the catalytic potency and the redox properties of Mn complexes controls their ability to impact cellular redox environment and thus enhance the radiation and ascorbate-mediated tumor suppression. Conclusions: The interplay between the accumulation of cationic MnPs and their potency as catalysts for oxidation of Asc, protein cysteines, and GSH controls the magnitude of their anticancer therapeutic effects.
- 20 September 2018
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 29 (13) , 1196-1214
Radiation-Mediated Tumor Growth Inhibition Is Significantly Enhanced with Redox-Active Compounds That Cycle with Ascorbate
Aims: We aim here to demonstrate that radiation (RT) enhances tumor sensitization by only those Mn complexes that are redox active and cycle with ascorbate (Asc), thereby producing H 2 O 2 and utilizing it subsequently in protein S -glutathionylation in a glutathione peroxidase (GPx)-like manner. In turn, such compounds affect cellular redox environment, described by glutathione disulfide (GSSG)/glutathione (GSH) ratio, and tumor growth. To achieve our goal, we tested several Mn complexes of different chemical and physical properties in cellular and animal flank models of 4T1 breast cancer cell. Four other cancer cell lines were used to substantiate key findings. Results: Joint administration of cationic Mn porphyrin (MnP)-based redox active compounds, MnTE-2-PyP 5+ or MnTnBuOE-2-PyP 5+ with RT and Asc contributes to high H 2 O 2 production in cancer cells and tumor, which along with high MnP accumulation in cancer cells and tumor induces the largest suppression of cell viability and tumor growth, while increasing GSSG/GSH ratio and levels of total S -glutathionylated proteins. Redox-inert MnP, MnTBAP 3− and two other different types of redox-active Mn complexes (EUK-8 and M40403) were neither efficacious in the cellular nor in the animal model. Such outcome is in accordance with their inability to catalyze Asc oxidation and mimic GPx. Innovation: We provided here the first evidence how structure-activity relationship between the catalytic potency and the redox properties of Mn complexes controls their ability to impact cellular redox environment and thus enhance the radiation and ascorbate-mediated tumor suppression. Conclusions: The interplay between the accumulation of cationic MnPs and their potency as catalysts for oxidation of Asc, protein cysteines, and GSH controls the magnitude of their anticancer therapeutic effects.